1. Introduction {#sec1}
===============

Cancers are complex disorders, and it is virtually impossible to prove what causes a particular cancer, because most cancers have multiple possible causes. However, we can classify cancer-related factors as risk or protective factors to assess preventative strategies. A hitherto unknown number of risk and protective factors contribute to cancer development by interacting with each other. Although cancer can develop at any age, cancer incidence increases with age \[[@B1]--[@B3]\]; therefore, it is believed that old age is the most important risk factor for cancer development and was treated as a major variable in the present study.

Worldwide, the rates of cancer are increasing, mainly related to the aging population and changes in lifestyle resulting from social development \[[@B4]--[@B6]\]. Some cancers seem to be more prevalent in people with a lower quality of life, whereas other cancers may be more prevalent in people with a higher quality of life \[[@B7]\]. Social development or urbanization will result in changes to cancer risk and protective factors, including aging, diet and obesity, lack of physical activity, smoking, radiation, infections, stress, and environmental pollutants \[[@B8]--[@B10]\], and their impact on the occurrence of cancer \[[@B11]--[@B13]\]. Therefore, in growing economies, whether the time trend of increased social development might influence the development and burden of cancer should be explored, which will allow us to identify and implement appropriate medical strategies. To date, there have been no comprehensive and quantitative two time point analyses on cancers.

The cancer incidence (201.7/100000) in China is similar to that of the overall worldwide incidence (197.9/100000) in 2018 \[[@B14]\]. China\'s ethnic composition is relatively simple and is presently undergoing rapid urbanization \[[@B15]--[@B17]\]. China\'s gross domestic product was 1.955 trillion USD in 2004 and 11.016 trillion USD in 2015 ([Figure 1](#fig1){ref-type="fig"}). Health and medical care has been markedly affected by economic growth, making China an ideal model to study disease patterns associated with modernization \[[@B18]--[@B20]\]. In this study, we analyzed the characteristics of cancers using two properties: (1) age \[[@B8]\] and (2) risk factors \[[@B7]\]. The results showed that although these two properties varied significantly among some cancers, the rates of most cancers were unchanged with time. We also categorized 17 major cancers using two time point analysis and found that about 30% of cancers were sensitive to social development, and more than 60% of cancers were insensitive to social development. An improved understanding of such associations would benefit the development of a theoretical basis for cancer prevention and control strategies.

2. Materials and Methods {#sec2}
========================

2.1. Original Data {#sec2.1}
------------------

Original data was obtained from the 2004 and 2015 data sets of the national disease mortality surveillance system, which was edited by the Chinese Center for Disease Control and Prevention \[[@B21], [@B22]\], representing data obtained from over 73 million out of the 1.4 billion population of China between 2004 and 2015. In 2004, life expectancy at birth was 73.6 years, whereas in 2015, it was 76.1 years. The International Classification of Diseases- (ICD-) 10 codes \[[@B23]\] were used to classify the underlying causes of death, allowing us to determine the mortality statistics. Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"} show the raw data.

2.2. Two Time Point Analysis of Deaths Caused by Neoplasms {#sec2.2}
----------------------------------------------------------

The mortality rates in 2004 and 2015 were standardized using the 2000 Standard in China \[[@B7]\] and were used to calculate the ratio of change (RC) with time with respect to deaths caused by a particular cancer. The RC values were calculated using the following formula: $$\begin{matrix}
{RC = \frac{P_{1}}{P_{0}},} \\
\end{matrix}$$where *P*~1~ represents a cancer\'s mortality rate in 2015 and *P*~0~ represents the cancer\'s mortality rate in 2004.

An RC value \> 1 indicated that the mortality rate had increased with time, whereas a value \< 1 indicated a decreasing trend with time. To evaluate the degree of deviation from 1 (the values greater than 1 and those less than 1 were comparable), logarithmic transformation was used to transform the RC values into logarithms, with the absolute value, lnRC, serving as the quantitative value for the two time point analysis.

A scatter diagram was plotted using the lnRC values. The degree of deviation from 1 and the positions of the various cancers on the scatter diagram were used to sort neoplasms according to the changes in the mortality rate with time.

2.3. Assessing the Role of Age on Mortality from Cancer over Time {#sec2.3}
-----------------------------------------------------------------

To evaluate the mortality risk from aging and social development, a loglinear model using the Poisson regression was employed, with covariates of time (2004 and 2015) and a categorical age of 60 years old \[[@B7]\]. Poisson regression is a generalized linear model form of regression analysis used to model count data and contingency tables. Poisson regression assumes the response variable *Y* has a Poisson distribution and assumes the logarithm of its expected value can be modeled by a linear combination of unknown parameters. From the model, the *B* coefficients for the interaction between time and age were obtained, in which exp (*B*) was taken as the risk ratio. The greater the positive value of *B*, the greater the effect of the aging factor with time was on a particular cancer \[[@B7]\].

A probability of a type I error ≤ 0.05 was considered statistically significant. SPSS ver. 17.0 software for Windows (IBM, Armonk, NY, USA) was used to analyze the data statistically.

3. Results {#sec3}
==========

The two time point analysis of deaths caused by neoplasms is summarized and quantified in [Table 3](#tab3){ref-type="table"}. The contributions of time (social development) to different cancers varied: The lnRC value for the 17 neoplasms ranged from −1.04 to 0.38. The greater the lnRC, the greater the disease risk over time. In ascending order of lnRC were uterus; other malignant neoplasms; esophagus; stomach; skin; liver; leukemia; "lip, oral cavity, and pharynx"; bladder; "colon and rectum"; breast; prostate; lung; ovary; pancreas; "lymphoid, hematopoietic, and related tissue"; and cervix cancers.

[Table 4](#tab4){ref-type="table"} shows the results of the Poisson regression analysis to evaluate the mortality risk of aging with time (social development) for major cancers. We observed variations in the quantitative values of the effect of age with time on diseases. For the 17 cancers, the *B* value (the interaction between time and age) ranged from −0.169 to 0.435. A higher value of *B* indicated a stronger effect on cancer of aging with time (social development). The effect of aging with time was significantly reduced for cancers of the uterus, liver, pancreas, and cervix (*p* \< 0.05) and was significantly increased for cancers of the esophagus and leukemia (*p* \< 0.05).

According to their positions on the scatter diagram, the 17 neoplasms could be suggested to divide into three groups ([Figure 1](#fig1){ref-type="fig"}). Cancers located in the upper right were termed developed cancers (more prevalent in people with a higher quality of life) and comprised three cancers. Cancers in the lower left part were termed undeveloped cancers (more prevalent in people with a lower quality of life) and comprised four cancers. The third group, positioned between the developed and undeveloped groups, was termed as cancers insensitive to social development and comprised ten cancers (58.8%). [Figure 2](#fig2){ref-type="fig"} illustrates the detailed changes with social development for the three groups of cancers.

The constituent ratios of death from the three groups of cancers are shown in [Figure 3](#fig3){ref-type="fig"}. The constituent ratio increased from 4.9% in 2004 to 7.33% in 2015 for the developed cancers, decreased from 34.78% in 2004 to 25.06% in 2015 for the undeveloped cancers, and was approximately equal (60.84% in 2004 vs. 67.61% in 2015) for cancers insensitive to social development. The constituent ratios of death from insensitive to social development cancers were approximately two-thirds of all cancers.

4. Discussion {#sec4}
=============

Life expectancy at birth in 2004 was 73.6 years, and in 2015, it was 76.1 years. Therefore, our data for the two time point analysis could reveal the contribution of social development to the development of cancer. The results revealed that these contributions varied without consideration of age. In the 17 cancers studied, the lnRC value ranged from −1.04 to 0.38 ([Table 3](#tab3){ref-type="table"}), indicating that the contributions of social development to different cancers varied.

The greater the lnRC, the greater the risk of disease risk with time (social development). The lnRC data showed that among the 17 cancers studied, uterus cancer had the lowest disease risk with time (social development) and cervix cancer had the highest risk. The 17 neoplasms could be divided into developed cancers (for which social development might be a risk factor), undeveloped cancers (for which lack of social development might be a risk factor), and cancers insensitive to social development, according to their position on the scatter diagram ([Figure 2](#fig2){ref-type="fig"}). The constituent ratio of death from all cancers increased from 4.9% in 2004 to 7.33% in 2015 for developed cancers and decreased from 34.78% in 2004 to 25.06% in 2015 for undeveloped cancers ([Figure 3](#fig3){ref-type="fig"}). This suggested that the categories of cancer in this study are accurate and reasonable.

Unexpectedly, about 60% (as assessed by type of cancer) and two-thirds (as assessed by constituent ratio of death from all cancers) of cancers were insensitive to social development, which suggested that the improvement in social development and medical care might have played a limited role in altering the rate of death from cancers. Internal factors, including aging, might have a key effect on cancer occurrence.

Aging is a significant and uncontrollable risk factor for death \[[@B1], [@B24], [@B25]\]; therefore, determining the effects of aging on cancers with social development is important. The different contributions of age to mortality from cancers between 2004 and 2015 could also be considered as the change in the effect of other risk factors on cancers with time (social development). A larger difference indicated an increased effect of aging or a decreased effect of other risk factors on death resulting from cancers with social development. Therefore, changes in the effect of aging with time implied that the structure of the risk factors had changed with increasing social development. Our results showed that the *B* value (representing the interaction between time and age) for the 17 cancers ranged from −0.169 to 0.435. The effect of aging with social development was significantly reduced for cancers of the uterus, liver, pancreas, and cervix (*p* \< 0.05) and was significantly increased for cancers of the esophagus and leukemia (*p* \< 0.05), suggesting that the structure of risk factors had changed with increasing social development for these cancers. Moreover, for most of the cancers categorized as insensitive to social development, the level of risk and the structure of the risk factors had not changed with time ([Figure 3](#fig3){ref-type="fig"}).

The identification of a group of developed cancers, including cervix, pancreas, and "lymphoid, hematopoietic, and related tissue" cancers, showed that risk factors from social development have contributed to increases in the rates of some cancers. The risk factors might have a more important role in the relatively young population for cervix and pancreas cancers. Accordingly, an emphasis on avoiding risk factors from social development or urbanization might contribute to disease prevention for these developed cancers.

The presence of a group of undeveloped cancers, including uterus, esophagus, stomach, and other malignant neoplasms, showed that protective factors from social development have contributed to decreases in the rates of some cancers. The protective factors might have a more important role in the relatively young population for esophagus cancer and in the relatively old population for uterus cancer. Accordingly, disease prevention might be aided by an emphasis on public health and increasing basal health status for undeveloped cancers.

One limitation of this study is that the social development was not described with more indicators. Time and social development may not be equal. However, China\'s gross domestic product was 1.955 trillion USD in 2004 and 11.016 trillion USD in 2015; in 2004, life expectancy at birth was 73.6 years, whereas in 2015, it was 76.1 years. Therefore, time and social development may be parallel during 2004-2015. Increase of gross domestic product and rapid urbanization would change lifestyle; cancer-related risk would also be changed with this processes. Therefore, time could represent social development in this period. The findings also suggested that only about 30% of cancers are sensitive to changes in socioenvironmental factors over time. Analyzing and controlling external risk factors might lead to 30% of cancers being prevented, because the external factors leading to cancers are relatively controllable. Solutions to developed urbanized diseases mainly involve avoiding risk factors, which include tobacco use, overweight, physical inactivity, inadequate diet, sexually transmitted infections, alcohol consumption, and air pollution. General protective interventions for life quality, including nutritional status, lifestyle, and quality of social life, could potentially delay the aging process. Thus, the primary prevention of cancers will be aided by increasing our understanding of the categories of cancer affected by social development. Further studies are warranted to observe correlation between specific risk factors with social development and cancers for developing more available preventative strategies.
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![Cancer groups classified on the basis of sensitivity to time. RC: ratio of change with time; rank of lnRC: in order of cancers with lnRC with respect to deaths caused by a particular cancer.](BMRI2020-9043012.002){#fig2}
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###### 

Age-stratified number of deaths from major cancers in 2004 in China \[[@B21]\].

  Age    Cancers   Survival                                                                                                      
  ------ --------- ---------- ------ ----- ------ ----- ------ ---- ----- ----- ----- ---- ----- ----- ----- ----- ----- ------- ---------
  0-     0         0          0      0     1      0     0      2    0     0     0     0    0     0     2     35    13    53      688115
  1-     1         0          0      0     7      0     0      2    0     0     0     0    0     1     3     69    6     89      3030920
  5-     0         0          0      1     7      0     2      2    0     0     0     0    0     0     5     95    5     117     4604931
  10-    1         0          0      3     16     0     2      0    0     2     0     2    1     1     9     146   9     192     6443682
  15-    10        0          7      12    34     2     22     2    1     1     2     5    1     0     16    220   13    348     5900624
  20-    11        8          15     24    64     0     18     2    5     2     5     1    4     1     15    157   14    346     5467254
  25-    24        11         53     47    141    6     60     3    20    6     14    9    1     1     19    125   24    564     6299615
  30-    69        27         123    83    422    20    165    11   55    32    35    12   2     5     22    163   35    1281    6992522
  35-    114       81         302    123   777    41    365    12   136   65    69    13   0     9     54    205   44    2410    6360862
  40-    149       189        436    148   1144   45    575    13   205   104   104   32   4     18    52    149   67    3434    5173403
  45-    232       471        867    282   1810   96    1034   22   254   102   135   59   8     24    71    203   78    5748    5115691
  50-    337       852        1320   374   2190   141   1709   25   339   108   231   80   14    31    131   211   101   8194    4047509
  55-    305       1102       1761   430   2193   166   1950   30   238   117   166   50   19    41    110   154   126   8958    2957812
  60-    304       1427       2166   509   2120   241   2523   38   168   94    156   51   26    82    121   169   99    10294   2486122
  65-    359       1784       2816   686   2430   276   3363   60   184   102   201   62   74    132   150   192   150   13021   2125649
  70-    320       2046       3175   876   2232   328   3961   69   136   83    153   50   145   185   157   178   147   14241   1601637
  75-    183       1568       2526   751   1692   269   3045   68   127   64    120   38   140   186   123   126   128   11154   1022733
  80-    137       967        1571   525   1011   154   1755   65   72    59    83    25   124   149   80    77    109   6963    545697
  \>85   72        472        817    332   527    67    930    57   42    35    36    18   104   112   30    39    65    3755    308427

Neoplasms (ICD-10 codes): A: lip, oral cavity, pharynx (C00--C14); B: esophagus (C15); C: stomach (C16); D: colon, rectum (C18--C21); E: liver (C22); F: pancreas (C25); G: trachea, lung (C33--C34); H: skin (C43--C44); I: breast (C50); J: cervix (C53); K: uterus (C54--C55); L: ovary (C56); M: prostate (C61); N: bladder (C67); O: lymphoid, hematopoietic, related tissue (C81--C90, C96); P: leukemia (C91--C95); Q: other malignant neoplasms (C17, C23--C24, C26--C32, C37--C41, C45--C49, C51--C52, C57--C60, C62--C66, C68--C80, and C97); R: all cancers.

###### 

Age-stratified number of deaths from major cancers in 2015 in China \[[@B22]\].

  Age    Cancers   Survival                                                                                                              
  ------ --------- ---------- ------ ------ ------ ------ ------- ----- ------ ----- ----- ----- ----- ----- ------ ------ ----- ------- ----------
  0-     0         0          0      1      14     0      1       0     0      0     0     0     0     0     10     88     15    129     2804289
  1-     0         0          0      0      32     0      2       1     0      0     0     0     0     0     42     239    31    347     11836631
  5-     5         0          1      0      13     2      2       0     0      0     0     0     0     1     39     217    18    298     15322497
  10-    4         1          2      2      12     1      5       2     0      0     0     2     0     0     42     207    11    291     12042350
  15-    9         1          5      18     33     1      20      5     1      0     2     4     0     1     52     265    14    431     14609389
  20-    19        5          33     39     121    10     48      5     9      8     4     8     1     3     57     327    21    718     22895079
  25-    31        9          125    84     301    21     160     10    70     38    15    16    2     4     128    380    35    1429    18670345
  30-    77        14         209    168    671    43     280     18    165    112   28    34    2     8     99     322    44    2294    15611678
  35-    152       43         385    292    1405   72     660     17    335    187   74    53    4     13    143    352    59    4246    19793806
  40-    338       245        953    623    3386   241    1957    62    780    465   128   136   10    34    288    508    119   10273   22967145
  45-    582       792        1943   1104   5582   479    4174    78    1185   836   254   223   15    62    454    624    153   18540   26394480
  50-    737       1573       2899   1470   6787   759    6897    79    1408   938   300   351   44    128   632    670    220   25892   16034245
  55-    804       2613       4376   2035   7964   1231   10417   108   1343   800   341   331   86    217   774    730    250   34420   18285929
  60-    1025      4531       7151   3098   9985   1703   16323   153   1360   892   329   416   211   397   1109   1065   337   50085   14053811
  65-    900       5299       8031   3362   8808   1832   17509   192   861    716   339   349   281   520   1070   896    339   51304   9032555
  70-    733       5371       8314   3536   7551   1826   17546   202   652    594   228   273   508   658   1041   860    309   50202   6728141
  75-    694       5160       8422   4052   6600   1743   17766   237   587    518   229   211   840   891   932    815    385   50082   5350578
  80-    507       4122       6673   3645   4893   1424   13547   298   469    367   182   147   887   887   645    528    382   39603   3320829
  \>85   329       2607       4366   2727   3064   869    8259    361   405    250   99    88    826   830   335    270    282   25967   1817600

Neoplasms (ICD-10 codes): A: lip, oral cavity, pharynx (C00--C14); B: esophagus (C15); C: stomach (C16); D: colon, rectum (C18--C21); E: liver (C22); F: pancreas (C25); G: trachea, lung (C33--C34); H: skin (C43--C44); I: breast (C50); J: cervix (C53); K: uterus (C54--C55); L: ovary (C56); M: prostate (C61); N: bladder (C67); O: lymphoid, hematopoietic, related tissue (C81--C90, C96); P: leukemia (C91--C95); Q: other malignant neoplasms (C17, C23--C24, C26--C32, C37--C41, C45--C49, C51--C52, C57--C60, C62--C66, C68--C80, and C97); R: all cancers.

###### 

Two time point analysis of the mortality rate for different cancers.

  Cancers                          Standardized mortality rate (annual deaths per 10^5^ population)   RC       lnRC   *p*     
  -------------------------------- ------------------------------------------------------------------ -------- ------ ------- ---------
  Lip, oral cavity, and pharynx    2.07                                                               1.87     0.90   −0.11   \<0.001
  Esophagus                        14.02                                                              8.21     0.59   −0.53   \<0.001
  Stomach                          22.89                                                              13.80    0.60   −0.51   \<0.001
  Colon and rectum                 6.62                                                               6.68     1.01   0.01    \<0.001
  Liver                            24.28                                                              18.01    0.74   −0.30   \<0.001
  Pancreas                         2.37                                                               3.14     1.32   0.28    \<0.001
  Trachea and lung                 27.41                                                              29.59    1.08   0.08    \<0.001
  Skin                             0.61                                                               0.45     0.74   −0.30   \<0.001
  Breast                           2.57                                                               2.64     1.03   0.03    \<0.001
  Cervix                           1.26                                                               1.85     1.47   0.39    \<0.001
  Uterus                           1.95                                                               0.69     0.35   −1.05   \<0.001
  Ovary                            0.65                                                               0.72     1.11   0.10    \<0.001
  Prostate                         0.82                                                               0.85     1.04   0.04    \<0.001
  Bladder                          1.22                                                               1.12     0.92   −0.08   \<0.001
  Lymphoid, hematopoietic tissue   1.52                                                               2.20     1.45   0.37    \<0.001
  Leukemia                         3.69                                                               3.03     0.82   −0.20   \<0.001
  Other malignant neoplasm         1.59                                                               0.81     0.51   −0.67   \<0.001
  All cancers                      123.90                                                             106.14   0.86   −0.15   \<0.001

lnRC is the absolute RC (logarithmically transformed RC). A value \<1 indicated a decreasing trend of mortality with time.

###### 

The mortality risk from aging with time for major cancers using Poisson regression analysis.

  Group of cancers                    B                                95% CI   p                
  ----------------------------------- -------------------------------- -------- ---------------- ----------
  Undeveloped                         Uterus                           −0.144   −0.272\~−0.017   0.027
                                      Other malignancy                 0.090    −0.046\~0.225    0.196
                                      Esophagus                        0.164    0.112\~0.216     \<0.0001
                                      Stomach                          0.020    −0.019\~0.059    0.322
                                                                                                 
  Insensitive to social development   Skin                             −0.085   −0.317\~0.147    0.475
                                      Liver                            −0.052   −0.085\~−0.019   0.002
                                      Leukemia                         0.435    0.343\~0.528     \<0.0001
                                      Lip, oral cavity, and pharynx    −0.040   −0.130\~0.051    0.390
                                      Bladder                          −0.038   −0.245\~0.168    0.717
                                      Colon and rectum                 0.009    −0.058\~0.075    0.798
                                      Breast                           −0.023   −0.123\~0.076    0.647
                                      Prostate                         0.282    −0.037\~0.601    0.084
                                      Lung                             −0.028   −0.061\~0.005    0.093
                                      Ovary                            −0.041   −0.232\~0.149    0.670
                                                                                                 
  Developed                           Pancreas                         −0.124   −0.233\~−0.014   0.027
                                      Lymphoid, hematopoietic tissue   −0.005   −0.130\~0.119    0.931
                                      Cervix                           −0.169   −0.304\~0.034    0.014
                                      All cancers                      −0.002   −0.017\~0.014    0.809

B: measure of the interaction between time and age (a positive value of B indicates an increased aging risk with time); CI: confidence interval.
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